Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2011-005273-23-GB
EUCTR2011-005273-23-GB
Active, not recruiting
Phase 1

HEAT-PPCI - How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention - A randomised controlled trial to compare unfractionated heparin versus bivalirudin in the treatment of patients with a clinical diagnosis of ST-segment elevation myocardial infarction, for planned management with primary PCI - How Effective are Antithrombotic Therapies in Primary PCI: HEATppci v1

iverpool Heart and Chest Hospital0 sites1,800 target enrollmentDecember 12, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsHeparin Sodium (Unpreserved)Angiox

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
iverpool Heart and Chest Hospital
Enrollment
1800
Status
Active, not recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2011
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
iverpool Heart and Chest Hospital

Eligibility Criteria

Inclusion Criteria

  • •Patients presenting to participating centres with an ST elevation myocardial infarction event with PPCI as the proposed index reperfusion strategy
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 900
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 900

Exclusion Criteria

  • •\= 18 years of age
  • •\>12 hours since onset of severe pain
  • •Known intolerance, hypersensitivity or contraindication to any trial
  • •Active bleeding at presentation
  • •Artificial ventilation, reduced conscious level or other factors precluding
  • •the administration of oral anti\-platelet therapy
  • •Previous enrolment in this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary InterventioAtrial Fibrillation Coronary Artery Disease
JPRN-UMIN000022004Department of Clinical Epidemiology, Hyogo College of Medicine5,000
Completed
Phase 4
The efficacy and safety of the antiplatelet therapy in acute non-cardiogenic ischemic stroke.on-cardiogenic ischemic stroke in acute phase.
JPRN-UMIN000006931Department of Neurosurgery, Faculty of Medicine, University of Tsukuba130
Completed
Not Applicable
Evaluation of the efficacy and safety of thromboprophylaxis regimens in patients after the Fontan procedurePatients after the Fontan procedure
JPRN-UMIN000044127Showa University1,903
Completed
Not Applicable
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarction
JPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
Not Applicable
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)
JPRN-UMIN000021138ihon University school of medicine150